Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy. Wilkinson S, Sowalsky AG. J Natl Cancer Inst 2024;116:12-14.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wilkinson S, Sowalsky AG. Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy. J Natl Cancer Inst 2024;116:12-14.
PMID: 37816132